230 related articles for article (PubMed ID: 11444639)
1. A critical review of clinical trials for low-molecular-weight heparin therapy in unstable coronary artery disease.
Husted S; Becker R; Kher A
Clin Cardiol; 2001 Jul; 24(7):492-9. PubMed ID: 11444639
[TBL] [Abstract][Full Text] [Related]
2. Acute and prolonged treatment with low-molecular-weight heparin therapy in patients with unstable coronary artery disease.
Husted S; Kher A
Ann Med; 2000 Dec; 32 Suppl 1():53-9. PubMed ID: 11209983
[TBL] [Abstract][Full Text] [Related]
3. Improving outcomes in acute coronary syndromes--the FRISC II trial.
Kontny F
Clin Cardiol; 2001 Mar; 24(3 Suppl):I3-7. PubMed ID: 11286312
[TBL] [Abstract][Full Text] [Related]
4. Combination of low molecular weight heparins with antiplatelet agents in non-ST elevation acute coronary syndromes: an update.
Cohen M
Drugs; 2002; 62(12):1755-70. PubMed ID: 12149045
[TBL] [Abstract][Full Text] [Related]
5. Long-term management--the way forward?
Wallentin L
Clin Cardiol; 2000 Jan; 23 Suppl 1(Suppl):I13-7. PubMed ID: 10680039
[TBL] [Abstract][Full Text] [Related]
6. Low molecular weight heparin in unstable coronary artery disease.
Wallentin L
Expert Opin Investig Drugs; 2000 Mar; 9(3):581-92. PubMed ID: 11060697
[TBL] [Abstract][Full Text] [Related]
7. Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC).
Klein W; Buchwald A; Hillis SE; Monrad S; Sanz G; Turpie AG; van der Meer J; Olaisson E; Undeland S; Ludwig K
Circulation; 1997 Jul; 96(1):61-8. PubMed ID: 9236418
[TBL] [Abstract][Full Text] [Related]
8. Low molecular weight heparin in acute coronary syndrome: evidence for superior or equivalent efficacy compared with unfractionated heparin?
Kaul S; Shah PK
J Am Coll Cardiol; 2000 Jun; 35(7):1699-712. PubMed ID: 10841215
[TBL] [Abstract][Full Text] [Related]
9. The role of low-molecular-weight heparins in cardiovascular medicine.
Hödl R; Klein W
J Clin Pharm Ther; 2003 Oct; 28(5):371-8. PubMed ID: 14632961
[TBL] [Abstract][Full Text] [Related]
10. Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes.
Magee KD; Sevcik W; Moher D; Rowe BH
Cochrane Database Syst Rev; 2003; (1):CD002132. PubMed ID: 12535430
[TBL] [Abstract][Full Text] [Related]
11. Low-molecular-weight heparins and unstable angina--current perspectives.
Turpie AG
Haemostasis; 1997; 27 Suppl 1():19-24. PubMed ID: 9439754
[TBL] [Abstract][Full Text] [Related]
12. Role of low-molecular-weight heparins in the management of patients with unstable angina pectoris and non-Q-wave acute myocardial infarction.
Monrad ES
Am J Cardiol; 2000 Apr; 85(8A):2C-9C. PubMed ID: 10793174
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulants in acute coronary syndromes.
Turpie AG
Am J Cardiol; 1999 Sep; 84(5A):2M-6M. PubMed ID: 10505536
[TBL] [Abstract][Full Text] [Related]
14. Dalteparin for acute coronary syndromes.
O'Loughlin DC
Heart Dis; 1999; 1(5):329-36. PubMed ID: 11720639
[TBL] [Abstract][Full Text] [Related]
15. Implications of the Organization to Assess Strategies for Ischemic Syndromes-2 (OASIS-2) study and the results in the context of other trials.
Fox KA
Am J Cardiol; 1999 Sep; 84(5A):26M-31M. PubMed ID: 10505540
[TBL] [Abstract][Full Text] [Related]
16. Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group.
Lancet; 1996 Mar; 347(9001):561-8. PubMed ID: 8596317
[TBL] [Abstract][Full Text] [Related]
17. Low-molecular-weight heparins in the management of unstable angina.
Agnelli G; Sonaglia F
Haemostasis; 2000; 30 Suppl 2():158-67; discussion 146-7. PubMed ID: 11251362
[TBL] [Abstract][Full Text] [Related]
18. Rebound thrombin generation after heparin therapy in unstable angina. A randomized comparison between unfractionated and low-molecular-weight heparin.
Bijsterveld NR; Moons AH; Meijers JC; Tijssen JG; Büller HR; Levi M; Peters RJ
J Am Coll Cardiol; 2002 Mar; 39(5):811-7. PubMed ID: 11869846
[TBL] [Abstract][Full Text] [Related]
19. New frontiers in the management of unstable coronary artery disease.
Turpie AG
Am J Cardiol; 1997 Sep; 80(5A):21E-24E. PubMed ID: 9296465
[TBL] [Abstract][Full Text] [Related]
20. Is the use of unfractionated heparin in acute coronary syndrome outmoded?
Chiquette E; Chilton R
Curr Atheroscler Rep; 2004 Mar; 6(2):94-100. PubMed ID: 15023292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
